Quality Investor

Omada Health, Inc.

Rank #72Hypergrowth

OMDA · Nasdaq · Healthcare

Omada Health, Inc. (OMDA) — Rank #72 by gross profitability (GP/assets 0.52) · ROE -5.1% · Piotroski F-Score 6 / 9.

As-of 2026-09-15 · CIK 0001611115 · all metrics point-in-time as of the filing date.

About

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States.

Show more

The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners.

The company was incorporated in 2011 and is headquartered in South San Francisco, California.

Industry
Health Information Services
Sector
Healthcare
State
DE
Filer Category
Non-accelerated filerEmerging growth company
Fiscal Year End
December 31

Segments

A revenue-by-segment breakdown is not available for OMDA. This is expected for a single-reportable-segment filer with no product/service revenue disaggregation, or for a company whose filings predate SEC’s XBRL viewer.